Literature DB >> 23508913

Use of the human colorectal adenocarcinoma (Caco-2) cell line for isolating respiratory viruses from nasopharyngeal aspirates.

K H Chan1, M K Yan, K K W To, S K Lau, P C Woo, V C C Cheng, W S Li, J F W Chan, H Tse, K Y Yuen.   

Abstract

The human colorectal adenocarcinoma-derived Caco-2 cell line was evaluated as a means isolating common respiratory viruses from nasopharyngeal aspirates for the diagnosis of respiratory diseases. One hundred eighty-nine direct immunofluorescence positive nasopharyngeal aspirates obtained from patients with various viral respiratory diseases were cultured in the presence of Caco-2 cells or the following conventional cell lines: LLC-MK2, MDCK, HEp-2, and A549. Caco-2 cell cultures effectively propagated the majority (84%) of the viruses present in nasopharyngeal aspirate samples compared with any positive cultures obtained using the panel cells (78%) or individual cell line MDCK (38%), HEp-2 (21%), LLC-MK2 (27%), or A549 (37%) cell lines. The differences against individual cell line were statistically significant (P = < 0.000001). Culture in Caco-2 cells resulted in the isolation of 85% (36/42) of viruses which were not cultivated in conventional cell lines. By contrast, 80% (24/30) of viruses not cultivated in Caco-2 cells were isolated using the conventional panel. The findings indicated that Caco-2 cells were sensitive to a wide range of viruses and can be used to culture a broad range of respiratory viruses.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23508913      PMCID: PMC7167083          DOI: 10.1002/jmv.23538

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


INTRODUCTION

Influenza A, influenza B, respiratory syncytial virus (RSV), parainfluenza virus (PIV), and adenovirus (AdV) represent the most common viruses causing acute respiratory diseases resulting in significant morbidity and mortality. Conventional culture methods used to isolate respiratory viruses are based on tissue culture methods utilizing a panel of cell lines that include MDCK (Madin–Darby canine kidney), LLC‐MK2 (Rhesus monkey kidney), HEp‐2 (laryngeal cancer), A549 (human lung carcinoma), and RD (Rhabdomyosarcoma). Maintenance of different cell lines is complicated, cumbersome, requires long turnaround times, and is expensive. The RhMK (primary rhesus monkey kidney) cell line has been used for isolation of various respiratory viruses. However, the availability of primary cells, varying susceptibility to infection with different respiratory viruses, the potential of harboring endogenous foamy virus, and high costs limit the use of this cell line in diagnostic virology laboratories. Commercial R‐Mix (Mix cells with A549 and Mint Lung) and super E‐Mix (genetically engineered BGMK and Caco‐2 cells) have replaced the conventional cell line panel for the isolation of respiratory viruses [Lee et al., 1992; Buck et al., 2002; Weinberg et al., 2004]. Caco‐2 cells have also been used to isolate enteroviruses, enteric viruses, and influenza viruses [Reigel, 1985; Pintó et al., 1994; Yoshino et al., 1998; Chiapponi et al., 2010; Jahangir et al., 2010]. Several studies have also showed that Caco‐2 cells have the ability to propagate coronaviruses NL63 and SARS from culture isolates [Spiegel and Weber, 2006; Müller et al., 2010]. However, the efficacy of Caco‐2 cells in isolating common respiratory viruses directly from clinical samples remains unknown. In this study, the efficacy of isolating respiratory viruses from Caco‐2 cells was compared to isolation from the conventional cell line panel.

MATERIALS AND METHODS

Nasopharyngeal Aspirate Samples

Nasopharyngeal aspirates were sent to the virology laboratory for routine direct immunofluorescence antigen testing to diagnose infections caused by respiratory viral diseases and residual samples were used for this study. One hundred eighty‐nine nasopharyngeal aspirate specimens positive by direct immunofluorescence antigen confirmation were evaluated. The specimens were collected from 94 males and 95 females with a mean age of 30.4 years (range 1 month to 102 years of age). The positive direct immunofluorescence antigen testing identified 27 RSV, 38 influenza A, 32 influenza B, 20 PIV‐1, 11 PIV‐2, 30 PIV‐3, 18 PIV‐4, and 13 AdV isolates. This study was approved by the Institutional Review Board of the University of Hong Kong Hospital Authority, Hong Kong, West Cluster.

Viral Cultures

MDCK, LLC‐MK2, HEp‐2, A549, and Caco‐2 (ATCC HTB 37) cell monolayers grown in culture tubes were inoculated with 200 µl of each Nasopharyngeal aspirate sample and incubated at 35°C for 1 hr [Chan et al., 2008; Li et al., 2009]. MDCK and LLC‐MK2 cells were fed with 1 ml of serum‐free minimum essential medium (MEM) (GibcoBRL, Grand Island, NY) containing TPCK (tosylsulfonyl phenylalanyl chloromethyl ketone)‐treated trypsin (2 µg/ml) (Sigma, St. Louis, MO), and antibiotics (Garamycin, 0.02 mg/ml, Schering‐Plough Corporation, Heist‐op‐den‐Berg, Belgium; penicillin–streptomycin, 100 units/ml, GibcoBRL; nystatin, 20 units/ml, Sigma). Caco‐2; HEp‐2, and A549 cells were fed with 1 ml of MEM supplemented with 1% fetal calf serum (GibcoBRL) and antibiotics. Culture tubes were incubated using a roller apparatus at a speed of 12–15 revolutions per hour at 35°C. The cultures were then examined for virus‐induced cytopathic effect (CPE) daily for up to 10 days. At the end of the incubation period, or when CPE was detected, a cell scraper was used to collect cells that were mounted subsequently on Teflon‐coated slides, fixed, and immunostained with IMAGEN™ respiratory screen and typing reagents (Oxoid, Hampshire, UK) specific for viral antigens.

Direct Immunofluorescence Antigen Testing

Direct immunofluorescence antigen testing was carried out on nasopharyngeal aspirate specimens or culture‐infected cells as described previously [Chan et al., 2002]. Briefly, nasopharyngeal aspirate or infected cells were centrifuged, and the cell pellet washed in phosphate‐buffered saline (PBS). The cell pellet was then spotted on 6‐mm teflon‐coated slide wells, air dried, and fixed in ice‐cold acetone for 10 min. Smears were stained with IMAGEN™ respiratory screen and typing reagents for influenza virus type A and B, RSV, PIV screen and typing, AdV (Oxoid), and PIV‐4 (Millipore, Temecula, CA) and viewed at a magnification of 400× under epi‐fluorescence illumination using the fluorescein isothiocyanate (FITC) filter of a fluorescence microscope (Euroimmun, Luebeck, Germany).

Nucleic Acid Extraction and PCR for Respiratory Viruses

Nucleic acids were extracted using the NucliSens EasyMAG automatic robotic platform (bioMerieux, Marcy‐l'Etoile, France) according to the manufacturer's instructions. Briefly, 250 µl of a nasopharyngeal aspirate sample was added to 2 ml of lysis buffer and the mixture incubated for 10 min at room temperature. Total nucleic acid was recovered in 55 µl of elution buffer after magnetic separation [Chan et al., 2008]. PIV were identified by a set of multiplex primers used to amplify the hemagglutinin‐neuraminidase gene of PIV‐1, ‐2, and ‐3 or the phosphoprotein gene of PIV‐4 [Aguilar et al., 2000].

Data Analysis

Sensitivity of detection for a particular cell line was defined as the number of positive cultures divided by the total number of direct immunofluorescence antigen test positive samples. Chi‐square analysis was used to compare the sensitivity between different cell lines. A P‐value of <0.05 was considered as statistically significant.

RESULTS

One hundred eighty‐five nasopharyngeal aspirate samples were direct immunofluorescence antigen positive for eight common respiratory viruses subsequently cultured in five cell lines: Caco‐2, A549, HEp‐2, LLC‐MK2, and MDCK (Table I). Overall the sensitivity of Caco‐2 cells [84% (159/189)] for recovery of these respiratory viruses was higher than the sensitivity of the cell panel [78% (147/189)], however, this difference was not statistically significant (P = 0.150). When the sensitivity was compared to individual cell lines in the panel (MDCK [38%], HEp‐2 [21%], LLC‐MK2 [27%], and A549 [37%]) detection differences were statistically significant (P = < 0.000001).
Table I

Comparison of the Caco‐2 Cell Line With Conventional Cell Lines Used in the Recovery of Respiratory Viruses From Nasopharyngeal Aspirate

Direct immunofluorescence antigen test positiveNumber of nasopharyngeal aspiratesCaco‐2 number positive (%)A549 number positive (%)HEp‐2 number positive (%)LLC‐MK2 number positive (%)MDCK number positive (%)
RSV2720 (74%)14 (52%)22 (81%)5 (19%)0%
Flu A3835 (92%)4 (11%)0%3 (8%)36 (95%)
Flu B3225 (78%)7 (22%)0%3 (9%)31 (97%)
PIV‐12016 (80%)20 (100%)0%20 (100%)3 (15%)
PIV‐21111 (100%)5 (45%)1 (9%)7 (64%)1(9%)
PIV‐33022 (73%)6 (20%)4 (13%)11 (37%)0%
PIV‐41818 (100%)1 (6%)1 (6%)2 (11%)1 (6%)
AdV1312 (92%)13 (100%)12 (92%)0%0%
Total189159 (84%)70 (37%)40 (21%)51 (27%)72 (38%)

RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.

Comparison of the Caco‐2 Cell Line With Conventional Cell Lines Used in the Recovery of Respiratory Viruses From Nasopharyngeal Aspirate RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus. CPE was observed for all virus‐infected Caco‐2 cells except PIV between days 3 and 8 (Fig. 1). CPE was observed for RSV, PIV‐1, ‐2, and AdV but not influenza virusinfected A549 cells between days 3 and 6. CPE was only observed for RSV, PIV‐4, and AdV infected HEp‐2 cells between days 2 and 5. CPE was not discernable in virus‐infected LLC‐MK2 cells except for RSV and PIV‐1 that induced CPE between days 3 and 7. Only influenza virus was able to induce CPE in MDCK cells between days 2 and 5. All virus‐infected cells developing or not developing CPE were also stained with a panel of fluorescein labeled monoclonal antibodies to confirm infection as described in Materials and Methods Section (Fig. 2).
Figure 1

CPE in Caco‐2 cells following infections with (A) RSV, (B) AdV, (C) Flu A, (D) Flu B, and (E) a virus negative nasopharyngeal aspirate.

Figure 2

Antigen expression in Caco2 cells identified by direct immunofluorescence staining using a panel of monoclonal antibodies specific for respiratory viruses. A: RSV, (B) AdV, (C) Flu A, (D) Flu B, (E) PIV‐1, (F) PIV‐2, (G) PIV‐3, (H) PIV‐4, and (I) a virus negative nasopharyngeal aspirate.

CPE in Caco‐2 cells following infections with (A) RSV, (B) AdV, (C) Flu A, (D) Flu B, and (E) a virus negative nasopharyngeal aspirate. Antigen expression in Caco2 cells identified by direct immunofluorescence staining using a panel of monoclonal antibodies specific for respiratory viruses. A: RSV, (B) AdV, (C) Flu A, (D) Flu B, (E) PIV‐1, (F) PIV‐2, (G) PIV‐3, (H) PIV‐4, and (I) a virus negative nasopharyngeal aspirate. The sensitivities of different combinations of conventional panel cell lines (LLC‐MK2, A549, MDCK, and HEp‐2) with Caco‐2 cells were 88%, 88%, 89%, and 87%, respectively (Table III). Of the 42 cultures that were negative using the conventional cell culture panel, 36 were positive when cultured with Caco‐2 cells. Conversely, 30 Caco‐2 cultures were negative and 24 were conventional panel positive (Table II). There were 6 PIV‐3 direct immunofluorescence antigen test positive specimens with negative viral cultures that were confirmed positive by RT‐PCR.
Table III

Different Caco‐2 Combinations With Panel Cell Lines Used in the Recovery of Respiratory Viruses

Cell linesRSV (n = 27)Flu A (n = 38)Flu B (n = 32)PIV‐1 (n = 20)PIV‐2 (n = 11)PIV‐3 (n = 30)PIV‐4 (n = 15)AdV (n = 13)Total culture positivePercentage positive (%)
Caco‐2203525161122181215984
Caco‐2 + A549223525201123181316788
Caco‐2 + MDCK203832161122181216989
Caco‐2 + HEp‐2253525161122181316587
Caco‐2 + LLC‐MK2233525201123181216788

RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.

Table II

Evaluation of Negative Cultures Following Culture With Panel Cells Compared to Culture With Caco‐2 Cells Resulting in Positive Viral Propagation and Vice Versa

Virus typePanel cells negativeCaco‐2 cells positiveCaco‐2 cells negativePanel cells positive
RSV2277
Flu A2233
Flu B1177
PIV‐10044
PIV‐24400
PIV‐3171182
PIV‐4161600
AdV0011
Total42363024

RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.

Evaluation of Negative Cultures Following Culture With Panel Cells Compared to Culture With Caco‐2 Cells Resulting in Positive Viral Propagation and Vice Versa RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.

DISCUSSION

In this study, Caco‐2 cells [84% (159/189)] were shown to be more efficient for propagating the most common respiratory viruses associated with clinical NPA samples compared to the conventional cell panel comprised of the MDCK [(38% (72/189)], HEp‐2 [21% (40/189)], A549 [38% (70/189)], and LLC‐MK2 [(27% (51/189)] cell lines used for virus propagation or positive by any cell line in the panel [78% (147/189)]. Caco‐2 cells were the most efficient cell line for isolating PIV‐2–4, and HEp2, MDCK, LLC‐MK2, and A549 were the most efficient cell lines for recovering RSV, influenza A and B, PIV‐1, and adenovirus, respectively (Table I). One of the major advantages of using Caco‐2 cells was that viruses were recovered from this cell line that could not be cultured using cell lines comprising the conventional cell panel (Table II). However, Caco‐2 cells required a 2–5 day‐longer incubation time for virus recovery compared to the other cell lines. The sensitivity was increased from 84% to 87–89% if Caco‐2 were used with any one of the cell lines comprising the conventional panel (Table III). In order to maximize the sensitivity and decrease costs, combining Caco‐2 and MDCK cells can be used during influenza seasons to isolate the maximum number of influenza viruses. Combinations of Caco‐2 with LLC‐MK2 or A549 cells can be used to culture other viruses at other times of the year. Different Caco‐2 Combinations With Panel Cell Lines Used in the Recovery of Respiratory Viruses RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus. Furthermore, the Caco‐2 cell line does not require the addition of trypsin to isolate influenza viruses because they already cleave viral HA0 into the HA1 and HA2 subunits [Yoshino et al., 1998; Chiapponi et al., 2010] and are susceptible to CPE [Zhirnov and Klenk, 2003]. PIV‐4 was reported to be quite difficult to isolate in cell culture [Laurichesse et al., 1999; Lau et al., 2005]. In this study, Caco‐2 cell cultures efficiently supported the replication of PIV, particularly PIV‐4 (Tables I and II). Human PIVs have often been associated with upper respiratory tract infections and other more severe disease, especially in immunocompromised patients [Woo et al., 2000; Cortez et al., 2001]. PIV‐4 was associated with an outbreak involving 38 institutionalized children and three staff members [Lau et al., 2005] and also played an important role in causing acute lower respiratory tract infections in children [Ren et al., 2011]. Although antigen detection using immunofluorescence and nucleic acid detection by RT‐PCR are widely used in clinical diagnostic laboratories, it is important to maintain viral cultures since viral isolates are important for carrying out detailed molecular studies that require sufficient amounts of viral nucleic acid. This is especially important during the first isolation and characterization of new viruses, such as the SARS coronavirus [Peiris et al., 2003]. A simple culture work flow will facilitate diagnostic virology services since clinical laboratories are the first to process these specimens and would therefore have the highest chance of isolating respective virus since sample storage may reduce viral culture yields if processed at a later time.
  21 in total

1.  Enhanced detection of respiratory viruses using the shell vial technique and monoclonal antibodies.

Authors:  S H Lee; J E Boutilier; M A MacDonald; K R Forward
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

2.  Isolation of human pathogenic viruses from clinical material on CaCo2 cells.

Authors:  F Reigel
Journal:  J Virol Methods       Date:  1985-12       Impact factor: 2.014

3.  Human parainfluenza virus 4 outbreak and the role of diagnostic tests.

Authors:  Susanna K P Lau; Wing-Kin To; Philomena W T Tse; Alex K H Chan; Patrick C Y Woo; Hoi-Wah Tsoi; Annie F Y Leung; Kenneth S M Li; Paul K S Chan; Wilina W L Lim; Raymond W H Yung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections.

Authors:  K H Chan; N Maldeis; W Pope; A Yup; A Ozinskas; J Gill; W H Seto; K F Shortridge; J S M Peiris
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

5.  Evaluation of R-Mix shell vials for the diagnosis of viral respiratory tract infections.

Authors:  Adriana Weinberg; Lori Brewster; Julia Clark; Eric Simoes
Journal:  J Clin Virol       Date:  2004-05       Impact factor: 3.168

6.  Comparison of mixed cell culture containing genetically engineered BGMK and CaCo-2 cells (Super E-Mix) with RT-PCR and conventional cell culture for the diagnosis of enterovirus meningitis.

Authors:  George E Buck; Marise Wiesemann; Linda Stewart
Journal:  J Clin Virol       Date:  2002-07       Impact factor: 3.168

7.  Use of the colonic carcinoma cell line CaCo-2 for in vivo amplification and detection of enteric viruses.

Authors:  R M Pintó; J M Diez; A Bosch
Journal:  J Med Virol       Date:  1994-11       Impact factor: 2.327

8.  Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR.

Authors:  J C Aguilar; M P Pérez-Breña; M L García; N Cruz; D D Erdman; J E Echevarría
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus.

Authors:  Martin Spiegel; Friedemann Weber
Journal:  Virol J       Date:  2006-03-29       Impact factor: 4.099

10.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

View more
  4 in total

1.  Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia.

Authors:  Doreen Muth; Victor M Corman; Benjamin Meyer; Abdullah Assiri; Malak Al-Masri; Mohamed Farah; Katja Steinhagen; Erik Lattwein; Jaffar A Al-Tawfiq; Ali Albarrak; Marcel A Müller; Christian Drosten; Ziad A Memish
Journal:  J Clin Microbiol       Date:  2015-07-08       Impact factor: 5.948

2.  Assessment of antigen and molecular tests with serial specimens from a patient with influenza A(H7N9) infection.

Authors:  Kwok-Hung Chan; Kelvin K W To; Jasper F W Chan; Clara P Y Li; Kit-Man Chan; Honglin Chen; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

3.  Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses.

Authors:  Jasper Fuk-Woo Chan; Garnet Kwan-Yue Choi; Alan Ka-Lun Tsang; Kah-Meng Tee; Ho-Yin Lam; Cyril Chik-Yan Yip; Kelvin Kai-Wang To; Vincent Chi-Chung Cheng; Man-Lung Yeung; Susanna Kar-Pui Lau; Patrick Chiu-Yat Woo; Kwok-Hung Chan; Bone Siu-Fai Tang; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

4.  In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19.

Authors:  Athene Hoi-Ying Lam; Jian-Piao Cai; Ka-Yi Leung; Ricky-Ruiqi Zhang; Danlei Liu; Yujing Fan; Anthony Raymond Tam; Vincent Chi-Chung Cheng; Kelvin Kai-Wang To; Kwok-Yung Yuen; Ivan Fan-Ngai Hung; Kwok-Hung Chan
Journal:  Diagnostics (Basel)       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.